Weill Cornell is a leader in Mohs’ micrographic surgery, the treatment of choice for the majority of high-risk basal cell and squamous cell cancers. Our physicians are also advancing the use of sentinel lymph node mapping and lymphadenectomy to track the spread of melanomas.
Our researchers are working to increase our understanding of the physiology and pathophysiology of the skin and to develop basic and clinical information leading to the development of new and improved treatments for diseases of the skin. Active areas of research include investigations into: how environmental influences such as ultraviolet radiation inhibit immune processes within the skin that can lead to cancer; the mechanisms by which the nervous system, psychology and stress influence immunity within the skin; the role of soluble adenylyl cyclase (an important enzyme regulating aspects of cell biology) in benign and malignant proliferations of the skin; and derangements in immunity that allow skin cancers to escape immunologic control.
- Andrew B. Avarbock, M.D., Ph.D.
- Richard David Granstein, M.D.
- Kira Minkis, M.D., Ph.D.
- George Varghese, M.D.
- Mathew C. Varghese, M.B.
- Horatio F. Wildman, M.D.
- Jonathan Hale Zippin, M.D., Ph.D.
1305 York Avenue & 70th Street, 9th floor
New York, NY 10021
Phone: (646) 962-DERM (3376)